01-21-2026Cross-posted from: HHS Press OfficeDeputy Secretary of Health and Human Services Jim O’Neill, in his role as Acting Director of the Centers for Disease Control…
07-16-2025The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV have been updated.Cytomegalovirus…
11-20-2024The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV have been updated. Highlights from the updated…
06-05-2024Louis Shackelford of the HIV Vaccine Trials Network and NIH’s Carl Dieffenbach discuss why a safe, effective, and durable HIV vaccine is important for…
05-17-2024Cross-posted from: NIAID NowVaccines consistently transform public health, and HIV vaccine research has been a pillar of NIAID’s scientific mission since the…
05-01-2024A quick roundup of key topics of HIV.gov’s coverage of the 2024 Conference on Retroviruses and Opportunistic Infections from HIV testing, treatment, and PrEP…
12-20-2023Cross-posted from: NIAID Newsroom An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from…
09-26-2023Cross-posted from: NIAID newsroomA trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial…
09-13-2023Cross-posted from: CDC Newsroom CDC recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes…
07-25-2023On Tuesday at the International AIDS Society’s 12th Conference on HIV Science (IAS 2023), HIV.gov continued our conversations about research highlights,…
06-08-2023Cross-posted from: NIH Director’s Blog Posted on June 6th, 2023 by Lawrence Tabak, D.D.S., Ph.D. In recent years, we’ve witnessed some truly inspiring progress…
03-10-2023Last month, HIV.gov had the opportunity to speak with our colleagues from NIH, CDC, and HRSA and with community members about the latest research on HIV and…
09-29-2022Dear Partners, [September 28, 2022], CDC is announcing expanded eligibility for monkeypox vaccination so that more people may receive the vaccine before they…
09-12-2022Cross-posted from Centers for Disease Control and PreventionOn Friday, September 9, 2022, CDC issued in its Morbidity and Mortality Weekly Report (MMWR) the…
09-09-2022Cross-posted from NIAID Newsroom NIH Trial is Evaluating Intradermal Delivery to Expand the Vaccine Supply. Interested volunteers can visit clinicaltrials.gov…
03-23-2022Cross-posted from NIAID NewsroomPhase 1 Study Is Among First to Examine mRNA Technology for HIVThe National Institute of Allergy and Infectious Diseases (NIAID…
01-24-2022January is Cervical Health Awareness Month. For women with HIV, the observance is an important reminder of their greater risk of cervical cancer and the…
12-15-2021Cross-posted from the NIAID NewsroomNIAID Scientists Developed Vaccine PlatformAn experimental HIV vaccine based on mRNA—the same platform technology used in…
07-14-2021The U.S. Department of Health and Human Services (HHS) recently published two updates to its Guidelines for the Prevention and Treatment of Opportunistic…
03-09-2021In an HIV.gov video conversation yesterday, NIH’s Dr. Carl Dieffenbach shared highlights from HIV research presented at the 2021 virtual Conference on…